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Abstract
Background: Most neurodegenerative diseases are age-related disorders; however, how aging predisposes the
brain to disease has not been adequately addressed. The objective of this study is to determine whether
expression of proteins in the cerebromicrovasculature related to inflammation, oxidative stress and neurotoxicity is
altered with aging.
Methods: Brain microvessels are isolated from Fischer 344 rats at 6, 12, 18 and 24 months of age. Levels of
interleukin (IL)-1b and IL-6 RNA are determined by RT-PCR and release of cytokines into the media by ELISA. Vessel
conditioned media are also screened by ELISA for IL-1a, monocyte chemoattractant protein-1 (MCP-1), tumor
necrosis factor-a, (TNFa), and interferon g (IFNg). Immunofluorescent analysis of brain sections for IL-1b and IL-6 is
performed.
Results: Expression of IL-1b and IL-6, both at RNA and protein levels, significantly (p < 0.01) decreases with age.
Levels of MCP-1, TNFa, IL-1a, and IFNg are significantly (p < 0.05-0.01) lower in 24 month old rats compared to 6
month old animals. Immunofluorescent analysis of brain vessels also shows a decline in IL-1b and IL-6 in aged rats.
An increase in oxidative stress, assessed by increased carbonyl formation, as well as a decrease in the antioxidant
protein manganese superoxide dismutase (MnSOD) is evident in vessels of aged animals. Finally, addition of
microvessel conditioned media from aged rats to neuronal cultures evokes significant (p < 0.001) neurotoxicity.
Conclusions: These data demonstrate that cerebrovascular expression of proteins related to inflammation,
oxidative stress and neurotoxicity is altered with aging and suggest that the microvasculature may contribute to
functional changes in the aging brain.
Background
Diseases of the CNS are for the most part age-associated
disorders. A direct relationship exists between aging and
increasing incidence of neurodegenerative disease [1]. In
age-associated diseases inflammation and oxidative
damage are important features of brain pathology and
are often found together [2]. Despite a large body of
data linking inflammation and oxidative stress to the
pathology in age-related diseases, there is insufficient
knowledge about the effects of aging alone, in the
absence of disease, on inflammatory mediators and oxi-
dative stress in the brain.
An age-related increase in plasma and circulating
levels of tumor necrosis factor - alpha (TNFa), interleu-
kin-1 beta (IL-1b), interleukin-6 (IL-6), tumor necrosis
factor receptor (TNFRs) and interleukin-1 receptor
antagonist (IL-1RA) [3-6] has been shown in some stu-
dies, while other investigations show no age-related
increases in TNFa or IL-6 [7,8]. Similarly, an increase in
IL-6 is reported in a randomly selected population of
elderly Americans (70 and above) but not in a popula-
tion identified as “strictly healthy” [7]. Twenty-four hour
lipopolysaccharide (LPS) stimulation of whole blood
supernatants finds lower levels of TNFa and IL-1b but
not IL-6 in samples derived from elderly compared to
young control samples [9]. Animal studies comparing
young and aged rodents show a decrease in chemokine
expression in a dermal injury model but an increase in
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arteries in aged animals [10,11]. In addition, there is dis-
parity between cellular responsiveness and circulating
plasma levels. There is an increase in serum kinin levels
with aging but aortic endothelial cells from old Fischer
344 rats are hyporesponsive to exogenous bradykinin
[12]. In human studies, IL-6, but not IL-1b and TNFa
production by peripheral mononuclear cells is increased
in aged subjects compared to young cohorts [13]. The
effect of aging on the expression of cytokines and che-
mokines is controversial and inconsistent. In part, these
discrepancies could reflect heterogeneity among differ-
ent tissues examined. There is an increase in pro-infla-
matory cytokine expression, detected by microarray, in
coronary vessels of 25 month old Fischer 344 rats com-
pared to vessels of young rats [10]. In contrast, a study
examining the myocardial response to infarction in
senescent mice shows a decrease in neutrophil and
macrophage infiltration and reduced cytokine and che-
mokine expression in myocardial tissues compared to
young mice [14].
Oxidative stress, which results from an imbalance
between reactive oxygen species generation and antioxi-
dant enzyme capacity, is particularly important for the
brain because of its high metabolic rate. A number of
indices of oxidative stress such as protein oxidation,
lipid peroxidation, DNA oxidation and 3-nitrotyrosine
formation as well as diminished levels of antioxidants
such as superoxide dismutase (SOD) have been docu-
mented in neurodegenerative diseases [15]. In aging an
increase in the amount of oxidized proteins has been
reported, as measured by the level of intracellular pro-
tein carbonyls or nitrotyrosine [16]. Evidence from a
number of studies shows aging-associated accumulation
of oxidatively damaged DNA in the brain and other
organs with limited cell proliferation [17].
The brain microvasculature appears to be a site of con-
vergence for inflammatory and oxidative processes in neu-
rodegenerative disease. Isolated brain microvessels
o b t a i n e df r o mA l z h e i m e r ’s disease (AD) patients have
high levels of both cell-associated and soluble cytokines
and chemokines including IL-1b, IL-6, IL-8, TNFa, trans-
forming growth factor-b (TGF-b) and monocyte chemoat-
tractant protein-1 (MCP-1) compared to age-matched
non-AD controls [18-20]. Also, in AD a damaged micro-
circulation releases high levels of the reactive oxygen spe-
cies nitric oxide [21]. Finally, we document that in AD
dysfunctional microvessels release factors that are directly
injurious to neurons in culture [22]. Although age is the
dominant risk factor for the development of neurodegen-
erative disease, the effect of aging on inflammatory,
oxidative and neurotoxic processes in the brain microvas-
culature has not been explored. The possibility that the
cerebromicrovasculature is functionally altered in aging is
suggested by data showing that microvessels or vessel-con-
ditioned media from elderly non-demented patients,
although significantly less lethal than AD-derived vessels,
injures neurons in vitro [22].
The objective of the current study is to determine
whether expression of proteins in the cerebromicrovas-
culature related to inflammation, oxidative stress or
neurotoxicity are altered in an animal model of aging.
Materials and methods
Microvessel isolation and preparation of conditioned
media
Animal procedures were performed in accordance with
NIH “G u i d ef o rt h eC a r ea n dU s eo fL a b o r a t o r yA n i -
mals” and Texas Tech University Health Sciences Cen-
ter Institutional Animal Care and Use Committee
(IACUC) guidelines. Male Fisher rats 344 6, 12, 18 and
24 month old were purchased from NIA. The rats
weighed approximately 450 to 500 g. Upon delivery they
were housed in individual ventilated cages with bedding
and free access to water for a week prior to microvessel
isolation. Each age group consists of 24 male Fisher 344
rats and the microvessel isolation performed in triplicate
[23]. Cerebral cortices were homogenized in cold Hank’s
balanced salt solution (HBSS) without calcium and the
homogenate centrifuged at 3000 g for 15 min at 4°C.
The pellet was resuspended in cold HBSS containing
15% dextran and 5% fetal bovine serum (FBS) and cen-
trifuged at 4500 g for 20 min at 4°C. The supernatant
discarded and the pellet filtered through a 150 μms i e v e
and microvessels collected on a 53 μm sieve. Microves-
sels were resupended in Dulbecco’sm o d i f i e dE a g l e ’s
medium (DMEM) containing 10% FBS and dimethyl
sulfoxide and stored frozen in liquid nitrogen until use.
The purity of the microvessel preparations was assessed
by phase contrast microscopy.
Microvessels from 6,12,18 and 24 month old rats were
thawed and centrifuged at 2000 g for 15 min. Microves-
sels (50 μg/sample) were washed three times with cold
HBSS and resuspended in 500 μls e r u m - f r e eD M E M
containing 1% lactalbumin hydrolysate (LAH) for 8 h at
37°C in a 95% CO2/5% O2 incubator and then centri-
fuged (2000 g). Supernatants were collected for neuro-
toxicity analysis and determination of inflammatory
proteins.
Cerebral cortical cell culture and measurement of
neuronal cell death
Rat cerebral cortical cell cultures were prepared as pre-
viously described [22,24]. Cortices were isolated from 17-
day gestation rat fetuses, washed with HBSS, triturated in
10 ml Brooks-Logan solution containing 0.025% trypsin
and centrifuged for 10 min at 800 g. The supernatant was
discarded and the pellet was triturated and filtered
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sity of 500,000/ml in media containing DMEM supple-
mented with 2 mM
L-glutamine, 10% heat-inactivated horse serum, and
antibiotic/antimycotic on 6-well plates coated with poly-
L-lysine. Experimental treatments were carried out on
day 8 in Neurobasal medium containing N-2 supple-
ment, 0.5 mM L-glutamine and antibiotic/antimycotic
(treatment medium).
For the neurotoxicity assay, cerebral cortical cell cul-
tures were incubated with 100 μl conditioned media for
24 h. Neuronal cells were washed with phosphate buf-
fered saline (PBS) and incubated with the MTT reagent
3-(4, 5-dimethylthiazol-2-yl)-2-5-diphenyl tetrazolium
bromide reagent (1:40 dilution) for 5-10 min at 37°C.
The formazon product, which is produced only by live
cells, was quantified by colorimetric assay at 490 nm
(Cell Titer 95 Aqueous solution cell proliferation assay,
Promega, Madison, WI). In each experiment, the num-
ber of control cells i.e. viable cells not exposed to any
treatment was defined as 100%.
Measurement of protein carbonyl content
Protein carbonyl content in microvessels was deter-
mined using the OxyBlot protein oxidation detection kit
(Chemicon, Temecula, CA). Proteins extracted from
brain microvessels from 6, 12, 18 and 24 month old rats
were quantified using Bradford reagent. Equal amounts
of protein (5 μl) were denatured by adding 5 μlo f1 2 %
SDS. The proteins were derivatized by adding 10 μlo f2 ,
4 dinitrophenylhydrazine (DNPH). The derivatization
control solution without DNPH served as negative con-
trol. The samples were incubated at room temperature
for 15 min and neutralized with equal amounts of neu-
tralization solution. Both the treated sample and the
negative control were subjected to dot blot analysis.
Oxidized proteins were detected with anti-DNPH anti-
bodies provided in the kit. Band intensities were quanti-
fied using the Quanitity One software (Bio-Rad) and
represented as relative units.
Detection of inflammatory proteins by ELISA and RT-PCR
IL-6 and IL-1b released into the supernatant were
detected with rat custom 9 plex SL4638 Search Light sam-
ple testing service (Pierce Biotechnology, MA). To confirm
the testing service results ELISA measurements were per-
formed for IL-1b using ELISA kit RLB00 (R&D Systems,
MN), according to manufacturer’s instructions. Monocyte
chemotactic protein-1 (MCP-1), TNFa,i n t e r f e r o ng
(IFNg) and IL-1a were also determined by the rat custom
9 plex SL4638 Search Light sample testing service.
Total RNA was isolated from rat brain microvessels
with Trizol reagent (Invitrogen, Carlsbad, CA) and 1 μg
of RNA was reverse transcribed using oligo dT primers
(Roche Applied Science) and amplified by PCR. PCR
amplification was performed with cDNA, gene specific
primers (Table 1) as follows: denaturation for 2 min at
95°C, 30 cycles of 95°C for 40 sec, 55°C for 40 sec and
72°C for 2 min and a final extension at 72°C for 5 min.
The PCR products were visualized in a 1.5% agarose gel
containing 0.5 μg/ml ethidium bromide under UV
trans-illumination light with a gel documentation system
(Quantity One analysis software, Bio-Rad).
Western Blot determination of MnSOD
Total protein was extracted from microvessels with lysis
buffer containing 0.1% SDS, 1% Triton X-100 and 0.5%
phenylmethyl sulfonylfluoride. Protein estimation was
performed with Bradford reagent (Bio-Rad). Equal
amounts of protein were run on a 12% polyacrylamide
gel, transferred on to a PVDF membrane, blocked with
5% milk solution (non-fat dry milk in Tris-buffered sal-
ine Tween-20) and immuno-blotted with MnSOD (ab
16956,1:1000) and GAPDH (MAB374, 1:1000) primary
antibodies for 2 h. Membranes were washed with Tris-
buffered saline Tween-20 and incubated for 1 h with
peroxidase- conjugated secondary antibodies. After
extensive washing to remove unbound antibodies, mem-
branes were developed with chemiluminescence
reagents. Band intensities were quantitified using Quan-
tity One software (Bio-Rad) and graphically expressed as
intensity units which reflects the average intensity over
the area of the band normalized with that of GAPDH.
Immunofluorescence staining of brain tissue sections
Immunofluorescence labeling of rat brain tissue sections
was performed as described previously [25]. Briefly par-
affin sections (5 μm) were deparaffinized and rehydrated
in ethyl alcohol (100% to 70%). After heat-induced epi-
tope antigen retrieval, sections were washed in Tris-buf-
fered saline with Tween (TBST), blocked with 10%
donkey serum at room temperature for 2 h and sections
incubated at 4°C overnight with primary antibodies
against: IL-1b (1:50, sc-7884, Santa Cruz Biotechnology,
CA), IL-6 (1:50, sc-1265-R, Santa Cruz Biotechnology,
CA), MnSOD (1:200, ab16956, Abcam) or Von Willeb-
rand Factor (VWF) (1:50, sc-8068, Santa Cruz
Table 1 Primers used for RT-PCR
Gene Orientation Sequence Amplicon
Size (bp)
IL-1b Left primer AGCAGCTTTCGACAGTGAGGAGAA 182
Right primer TCTCCACAGCCACAATGAGTGACA
IL-6 Left primer CCGGAGAGGAGACTTCACAG 428
Right primer GAGCATTGGAAGTTGGGGTA
GAPDH Left primer TCTGCATCTGGCAAAGTGGAGACT 101
Right primer TTGAACTTGCCGTGGGTAGAGTCA
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serum. Following three washes with TBST, sections
were incubated with FITC conjugated secondary antibo-
dies (1:400, Invitrogen, Carlsbad, CA) at room tempera-
ture for 1 h. All sections were counter stained with
nuclear marker DAPI (blue). Fluorescent images were
captured using an Olympus IX71 microscope and quan-
tified with HAMAMATSU imaging software.
Statistical analysis
Data from each experiment were expressed as mean ±
standard deviation (SD). A one-way ANOVA followed
by Bonferroni’s multiple comparison tests for multiple
samples were performed. Statistical significance was
determined at p < 0.05.
Results
Microvessel-conditioned media from aged rats caused
neuronal cell death
Based on our previous work showing that microvessels
isolated from the brains of AD patients release neuro-
toxic factors [22], we examined the ability of isolated
brain microvessels to cause neuronal cell death as a
function of age. Microvessels isolated from Fischer 344
rats of 6, 12, 18, and 24 months of age were incubated
in serum free media for 8 h and the conditioned media
added to primary cortical cultures for 24 h. The results
showed that with increasing age conditioned media
from brain vessels evoked neuronal cell death. The abil-
ity of vessels to cause neuronal cell death was significant
(p < 0.01) at 18 months of age (Figure 1).
Aging increased oxidative stress and decreased
antioxidants in brain microvasculature
The oxidative modification of proteins by reactive oxy-
gen species can be quantitated by measurement of pro-
tein carbonyl content. In the current study protein
lysates from brain microvessels isolated from 6, 12, 18
and 24 month old rats were derivatized with 2, 4 dini-
trophenyl hydrazine. Dot blot analysis using an antibody
to DNPH showed an increase in vascular oxidative
stress with age (Figure 2a). Densitometric scan of the
data demonstrated that this increase was significant (p <
0.01) in animals 24 months of age (Figure 2b).
Because increased oxidative stress could reflect
increased radical generation, diminished antioxidant capa-
city or both, we explored the vascular expression of the
antioxidant protein MnSOD in brain sections of rats at 6
and 24 months of age. Immunofluorescent results showed
that reactivity to the MnSOD antibody was clearly evident,
as demonstrated by fluorescence (green) staining in the
blood vessels walls of animals 6 months of age (Figure 3).
In contrast, blood vessels from animals 24 months of age
show little to no detectable staining for MnSOD.
Figure 1 Microvessels isolated from 6, 12, 18 and 24 month
old rats were resuspended in serum-free media for 8 h, equal
volumes of conditioned medium (50 μl) was added to cerebral
cortical cultures and incubated for 24 h at 37°C. Cell viability
was determined by MTT assay. Viable cells not exposed to
conditioned medium were defined as 100%. Results are mean ± SD
from 2 separate experiments performed in triplicate. **p < 0.01 vs. 6
months; ***p < 0.001 vs. 6 months.
Figure 2 Protein lysates from microvessels of 6, 12, 18 and 24
month old rats were derivatized with diphenyhydrazine
(DNPH) and carbonyl formation identified with anti-DNPH. Dot
blot assay from 3 experiments (R1-R3) is shown in Figure 2a.
Densitometric scan of dot blots (2b) is representative of 3
experiments performed in triplicate. **p < 0.01 vs. 6 months.
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significant (p < 0.001) decrease in enzyme expression in
vessels from old animals compared to vessels of young
animals. These results were further confirmed by western
blot (Figure 4). Expression of MnSOD examined in micro-
vessels from rats 6, 12, 18, and 24 months of age showed a
decrease in MnSOD level that was significant (p < 0.01) at
18 months of age (Figure 4).
Brain vascular expression of inflammatory proteins
decreased with age
We examined the ability of brain microvessels isolated
from rats of different ages (6, 12, 18, 24 months) to
release the cytokines IL-1b and IL-6. Brain microvessels
isolated from these animals were incubated in serum-
free-media for 8 h and the media collected and assayed
by ELISA for IL-1b and IL-6. The amount of vascular-
derived IL-1b showed a progressive decrease from 6
months to 24 months of age. This decrease was signifi-
cant at 12 months (p < 0.01) and highly significant at 18
and 24 months of age (p < 0.001) (Figure 5a). Similarly,
release of IL-6 showed an age-dependent decrease, with
large (90%) and significant (p < 0.01) decrease at 24
months of age (Figure 5b).
An examination of cytokine expression at the RNA
level confirmed an age-dependent decrease in mRNA for
IL-1b (Figure 6a) and IL-6 (Figure 6b) when compared to
the expression of the housekeeping gene GAPDH.
To further confirm these data, we examined the
expression of IL-1b and IL-6 protein in tissue sections
using immunofluorescent staining. The results indicated
that reactivity to the antibody for IL-1b was intense in
blood vessels from rats 6 months of age but significantly
(p < 0.01) less (64.2%) in blood vessels from rats 24
months of age (Figure 7). Results obtained with antibody
to IL-6 also indicated intense green fluorescent labeling
in blood vessels from young rats (6 months of age),
whereas staining was significantly (p < 0.05) lower in
vessel walls from animals 24 months of age (Figure 8).
An examination of microvessel-conditioned media
from rats 6, 12, 18 and 24 months of age for levels of
inflammatory proteins IL-1a,M C P - 1 ,T N F a,a n dI F N - g
Figure 3 Brain tissue sections from 6 and 24 month old Fisher
344 rats were stained for nuclear stain DAPI (blue) and either
MnSOD (green) or the endothelial cell specific marker VWF
(red). Quantitative comparison of MnSOD expression between
vessels derived from 6 month and 24 month old animals is shown
in bar graph. Data are mean ± SD (n = 6). ×20. ***p < 0.001 vs. 6
months.
Figure 4 Total protein extracted from brain microvessels
obtained from 6, 12, 18 and 24 rats was resolved with 12%
SDS-PAGE gel. MnSOD and GAPDH were detected with specific
antibodies. Lower panel shows the relative intensity of bands of
MnSOD to GAPDH. Data are mean ± SD from 3 experiments. **p <
0.01 vs. 6 months; ***p < 0.001 vs 6 months.
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proteins as animals aged (Table 2).
Discussion
Results from the current studyi n d i c a t et h a te x p r e s s i o n
and release of cytokines IL-1b and IL-6 are reduced in
brain blood vessels with increased age. Release of IL-1a,
MCP-1, TNFa,a n dI F N - g from brain microvessels also
decreases with age. Futhermore, we document that anti-
oxidant protein expression decreases while oxidative
stress and release of neurotoxic factors increase in the
cerebromicrovasculature with age.
There are conflicting data as to whether indices of
inflammation, such as cytokine production, increase,
decrease or remain unchanged as humans or animals
age [7,26,27]. Some reports show an increase in levels of
circulating inflammatory proteins in the blood, including
TNFa and IL-6, as well as a positive correlation between
age and levels of IL-1b in isolated human monocyte cul-
tures stimulated with LPS [3-6,27]. On the other hand,
increasing age is associated with a decreased capacity of
the immune system to mediate effective immune
responses to vaccination and invading pathogens
Figure 5 Microvessels isolated from 6, 12, 18 and 24 month
old rat brains were incubated for 8 h in serum-free media and
the supernatant centrifuged (12,000 g, 15 min). IL-1b (5a) and
IL-6 (5b) released into the supernatant were determined using rat
custom 9 plex array ELISA (Pierce Biotechnology, MA). For IL-1b,
ELISA was also performed using a kit from R<D Systems. Data are
mean ± SD from 3 experiments performed in triplicate. * p < 0.05
vs. 6 months; **p < 0.01 vs. 6 months; ***p < 0.001 vs. 6 months.
Figure 6 Total RNA extracted from brain microvessels of 6, 12,
18 and 24 month old rats was reverse transcribed and
amplified with (a) IL-1b or (b) IL-6 specific primers. Amplified
products were visualized in 1.5% agarose gel and band intensity
represented as bars. Data were normalized relative to GAPDH
expression. Data are mean ± SD from 3 experiments performed in
triplicate. *p < 0.05 vs. 6 months; **p < 0.01 vs. 6 months.
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is referred to as immunosenescence. Inflammation, a
specialized immune response, might be expected to
decline with age. In this regard, LPS-stimulated whole
blood supernatants from elderly subjects exhibit lower
TNFa and IL-1b levels compared to samples from
young populations [9]. Differences in the health status
of elderly subjects may, in part, explain contradicting
results. Most human studies use volunteers that self-
report health status. Thus, elevated IL-6, arguably a
potential marker for a variety of diseases, could indicate
concomitant inflammatory disease and/or poor nutri-
tional status and indeed has been shown to be elevated
in the elderly where C-reactive protein (CRP), an indica-
tor of inflammation, is also high [13]. In this regard, a
study where subjects were rigorously screened for good
health found age did not influence basal secretion of IL-
6 from peripheral blood monocytes (PBMCs), and that
stimulated PBMCs from old patients produce less IL-6
than samples from young [7].
Experimental studies in animals that show contradic-
tory alterations in inflammatory mediator expression
and release with aging may reflect differences in tissue
source and/or cell type. Results of the current study are
focused exclusively on brain vascular changes. Compar-
ing expression of IL-1b and IL-6 between young and old
rats we document the decrease in cytokine expression at
the RNA level and protein level, using RT-PCR, ELISA
and immuno-histochemistry. At the protein level a
decrease in IL-1b and IL-6 is demonstrable both by a
rat custom 9 plex assay performed by Pierce Biotechnol-
ogy, and confirmed in our laboratory by ELISA.
Figure 7 Brain tissue sections from 6 and 24 month old Fisher
344 rats were stained for nuclear stain DAPI (blue) and either
IL-1b (green) or the endothelial cell specific marker VWF (red).
Quantitative comparison of IL-1b expression between vessels
derived from 6 month and 24 month old animals is shown in bar
graph. Data are mean ± SD (n = 3). ×20. **p < 0.01 vs. 6 months.
Figure 8 Brain tissue sections from 6 and 24 month old Fisher
344 rats were stained for nuclear stain DAPI (blue) and either
IL-6 (green) or the endothelial cell specific marker VWF (red).
Quantitative comparison of IL-6 expression between vessels derived
from 6 month and 24 month old animals is shown in bar graph.
Data are mean ± SD (n = 3). ×20. *p < 0.05 vs. 6 months.
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technique, expression of inflammatory proteins is pro-
nounced in the vasculature in brain tissue sections from
young animals and is greatly reduced in samples from
old rats. These data support the idea that vascular-
derived IL-1b and IL-6 decrease with age.
Whether specific cytokines are a trophic or toxic
influence in the brain is unclear. The cytokines IL-1b
and IL-6 are produced within the CNS, and similar to
the periphery, they exhibit pleiotropic and contradictory
functions. IL-1b has been identified as a mediator of
several forms of neurodegeneration in the brain. Intra-
cerebral administration of IL-1b results in acute brain
injury characterized by apoptotic cell death and elevated
expression of amyloid beta precursor protein [32]. In rat
glial-neuronal cultures IL-1b induces neuronal cell
death, via astrocytic release of matrix metalloproteinase-
9 [33]. In contrast, cultured neurons treated with IL-1b
are protected against the neurotoxic effects of NMDA-
mediated injury; an effect dependent on IL-1b-mediated
release of nerve growth factor [34]. Also, the protective
effect afforded by ischemic preconditioning is associated
with an increase in IL-b, indicating the importance of
timing [35]. In a similar manner, IL-6 can produce
either deleterious or beneficial effects on neuronal func-
tion. IL-6 protects neurons against glutamate- and
NMDA excitotoxicity in vitro and prevents brain from
ischemic or excitotoxic attacks in vivo [34,36]. However,
other studies have implicated IL-6 in the pathogenesis
of neurodegenerative disorders [37]. Finally, experiments
using neuronal-astrocytic cultures show that IL-6 is
both neuroprotective and neurotoxic, depending on con-
centration [38]. Taken together, data highlight the
importance of context in determining functional signifi-
cance of inflammatory protein expression.
A consistent literature indicates that oxidative stress is
a feature of neurodegenerative diseases and aging
[reviewed in [39]]. The oxidative stress-free radical
theory of aging proposes that endogenously produced
oxygen radicals are a basic cause of progressive
age-associated declines in tissue function [40]. In addi-
tion, there are complex interactions between inflamma-
tory proteins and oxidative stress. For example, IL-6 has
been shown to protect PC12 neuronal cells from 4-
hydroxynonenal-induced cytotoxicity by an increase in
intracellular glutathione levels [41]. Addition of an anti-
oxidant grape seed extract improves survival of cultured
neurons exposed to H2O2 via release of IL-6 [42]. In the
current study we document a progressive increase in
vascular carbonyl content with increasing age. Elevated
protein carbonyl formation, the most widely studied
marker of protein oxidation, has been documented in
both normal aging as well as in AD [39,43]. Also, oxida-
tive stress reflects an imbalance between reactive species
generation and the ability of antioxidant systems to buf-
fer these radicals. An age-related attenuation of micro-
vascular antioxidant defenses has been suggested [44].
Our results show that reactivity to the MnSOD antibody
is robust in vessels from young animals, but is barely
detectable in vessels of aged Fischer 344 rats. This
decrease in the mitochondrial antioxidant MnSOD may
be especially relevant for the cerebral microcirculation
because endothelial cells have an extensive mitochon-
drial network [45]. Mitochondria are both sources of
and targets for reactive oxygen species, and there is
growing evidence that mitochondrial dysfunction may
be an important mediator of vascular lesions [46,47].
The brain vasculature appears especially sensitive to oxi-
dative stress. This sensitivity may in part be due to
higher levels of NAD(P)H-oxidase in brain endothelial
cells compared to endothelial cells in peripheral vessels.
In this regard, a recent study shows that the inflamma-
tory protein CRP evokes NAD(P)H-oxidase dependent
functional derangements in brain- but not aorta-derived
endothelial cells [48]. Our results, showing a decrease in
MnSOD and increase in vascular dysfunction, as evi-
denced by release of neurotoxins, are supported by stu-
dies that link decreased MnSOD with increased
endothelial dysfunction [49,50].
Dynamic communication between the cells of the neu-
rovascular unit is required for normal brain functioning
[51]. Endothelial cells are a key component of the neuro-
vascular unit and are highly synthetic cells. Activated
endothelial cells elaborate adhesion molecules, cytokines,
chemokines growth factors, vasoactive molecules, pro-
coagulant and anticoagulants moieties and variety of
other gene products with biologic activity. The activated
endothelium exerts direct local effects by producing para-
crine factors that act on adjacent cells [52]. Pathologically
activated or dysfunctional endothelial cells are key to the
development of the age-associated cardiovascular disease
atherosclerosis and are increasingly implicated in the
development of disorders of the CNS [53]. We have
shown synthesis and release of neurotoxic thrombin












IL-1a 1.87 ± 0.31 1.53 ± 0.23 1.13 ± 0.5 0.47 ± 0.12**
MCP-1 12.27 ± 1.22 7.9 ± 5.11 2.97 ± 1.87* 2.07 ± 1.21*
TNFa 7.40 ± 1.91 3.20 ± 1.73* 2.20 ± 0.0** 1.87 ± 0.58**
IFNg 21.6 ± 1.40 19.67 ± 1.47 14.43 ± 1.78 8.87 ± 5.99**
Microvessels isolated from 6, 12, 18 and 24 month old rat brains were
incubated for 8 h in serum-free media and the supernatant centrifuged
(12,000 g, 15 min). Proteins released into the supernatant were determined
using rat custom 9 plex array ELISA (Pierce Biotechnology, MA). Data are
mean ± SD from 3 experiments performed in triplicate. *p < 0.05 vs. 6 month;
**p < 0.01 vs. 6 month
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Page 8 of 10from the cerebro-microcirculation in AD [25]. In the cur-
rent study we document that aging, in the absence of dis-
ease, causes changes in brain blood vessels that result in
release of factors that are injurious to neurons. These
data highlight a role for vascular-derived products as
contributing to a noxious microenvironement for neu-
rons in the aging brain. Understanding how aging affects
vascular expression of inflammatory proteins, oxidative
stress markers, and neurotoxins could provide insight
into how aging predisposes the brain to development of
age-related diseases and suggest strategies to improve
brain function in aging.
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